Ancora Advisors’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Ancora Advisors’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,500	Closed	-$1K	–	2111
2022 Q4	$1K	Hold	17,500	–	–	﹤0.01%	1726
2022 Q3	$1K	Hold	17,500	–	–	﹤0.01%	1965
2022 Q2	$4K	Hold	17,500	–	–	﹤0.01%	1823
2022 Q1	$7K	Hold	17,500	–	–	﹤0.01%	1871
2021 Q4	$8K	Buy	+17,500	New	+$8.27K	﹤0.01%	1903

Other funds holding PEPLW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Ancora Advisors's PEPLW Position: Q1 2023 in Review

Ancora Advisors sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2023, closing a stake of 17,500 shares — an estimated $1K sold.

Ancora Advisors first reported a position in PEPLW in Q4 2021 and held it in 5 quarters. The position peaked at $8K in Q4 2021. 23 funds tracked by Wall St. Rank hold PEPLW as of Q1 2023.

Ancora Advisors reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2023 after selling out during the quarter.
Ancora Advisors sold 17,500 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2023, an estimated $1K.
Ancora Advisors first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 5 quarters.
Ancora Advisors's PepperLime Health Acquisition Corporation Warrrant position peaked at $8K in Q4 2021.
23 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.